Join us for an interesting discussion on how 3D bioprinting contributes to accelerating drug discovery and tissue engineering. Head of Sales Europe, Andrew Ridley, sits down with Hannah from the Society of Laboratory Automation and Screening (SLAS) to discuss CELLINK’s achievement in winning the New Product Award at SLAS Europe 2022. Andrew explains how the innovative biodispenser, the BIO CELLX, is a game changer for cancer research and drug development, due to its high-throughput capabilities and ease of use, making it suitable for all scientists without the need of prior tissue engineering experience.  

Andrew shares how different bioprinting technologies can reduce the amount of animal testing and provides a glimpse into what CELLINK has in store for future products.